Join to View Full Profile
2450 E River RdTucson, AZ 85718
Phone+1 520-795-7923
Fax+1 520-320-2155
Dr. Badruddoja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Neurology, 1999 - 2002
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1998 - 1999
Ross University School of MedicineClass of 1998
Certifications & Licensure
AZ State Medical License 2005 - 2027
CA State Medical License 2004 - 2026
IL State Medical License 1998 - 2001
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Publications & Presentations
PubMed
- Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma.Anna F Piotrowski, Kent Shih, Pierre Giglio, Howard Colman, Patrick Y Wen
Current Oncology. 2025-09-27 - 3 citationsAn expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs
CNS Oncology. 2023-09-01 - Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastomaMichael A. Badruddoja, Marjorie Pazzi, Abhay Sanan, Kurt Schroeder, Kevin Kuzma
Cancer Chemotherapy and Pharmacology. 2018-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
